Radioguided surgery in neuroendocrine tumors using Ga-68-labeled somatostatin analogs: A pilot study

Clinical Nuclear Medicine

Volumn 37, Issue 2, 2012, Pages 142-147

  Kaemmerer, Daniel ^a   Prasad, Vikas ^b   Daffner, Wolfgang ^a   Haugvik, Sven Petter ^a   Senftleben, Stefan ^b   Baum, Richard P ^b   Hommann, Merten ^a  

^a Zentralklinik Bad Berka ^*  (Germany)

^b ZENTRALKLINIK BAD BERKA   (Germany)

Author keywords

gallium 68; neuroendocrine tumors; PET CT; radioguided surgery; somatostatin receptor analogs

Indexed keywords

GALLIUM 68;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; NEUROENDOCRINE TUMOR; PILOT STUDY; RADIOSURGERY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOSURGERY; SOMATOSTATIN;

EID: 84855759431     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182291de8     Document Type: Article

References (38)

1. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61-72
2. OGrady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2008;34:324-332 (Pubitemid 351312867)
3. Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology. 2004;80:394-424 (Pubitemid 40874886)
4. Kaemmerer D, Prasad V, Daffner W, et al. Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor. World J Gastroenterol. 2009;15:5867-5870
5. Knigge U, Hansen CP, Stadil F. Interventional treatment of neuroendocrine liver metastases. Surgeon. 2008;6:232-239
6. Ochiai T, Komiyama S, Ikoma H, et al. A case report of metastatic neuroendocrine carcinoma of the right adrenal gland successfully treated with chemotherapy and surgery. Inte J Clin Oncol. 2010;15:423-427
7. Pederzoli P, Falconi M, Bonora A, et al. Cytoreductive surgery in advanced endocrine tumours of the pancreas. Ital J Gastroenterol Hepatol. 1999; 31(suppl 2):S207-S212 (Pubitemid 29527897)
8. Auernhammer CJ, Jauch KW, Hoffmann JN. Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system-therapeutic strategies in German. Zentralbl Chir. 2009;134:410-417
9. Eriksson B, Kloppel G, Krenning E, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumors-welldifferentiated jejunal-ileal tumor/carcinoma. Neuroendocrinology. 2008; 87:8-19 (Pubitemid 350308290)
10. Rindi G, de Herder WW, OToole D, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumors: the second event and some final considerations. Neuroendocrinology. 2008;87:5-7 (Pubitemid 350308289)
11. Lopci E, Nanni C, Rampin L, et al. Clinical applications of 68Ga-DOTANOC in neuroendocrine tumours. Minerva Endocrinol. 2008;33:277-281
12. Adams S, Baum RP. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. Q J Nucl Med. 2000;44:59-67 (Pubitemid 30325954)
13. Gulec SA. PET probe-guided surgery. J Surg Oncol. 2007;96:353-357 (Pubitemid 47509771)
14. Gulec SA, Baum R. Radio-guided surgery in neuroendocrine tumors. J Surg Oncol. 2007;96:309-315 (Pubitemid 47509765)
15. Gulec SA, Daghighian F, Essner R. PET-Probe: evaluation of technical performance and clinical utility of a handheld high-energy gamma probe in oncologic surgery. Ann Surgl Oncol. In press
16. Gulec SA, Hoenie E, Rheinheimer K. A multimodality localization technique for radio-guided surgery. World J Surg Oncol. 2007;5:43
17. Hubalewska-Dydejczyk A, Kulig J, Szybinski P, et al. Radio-guided surgery with the use of 99mTc-EDDA/HYNIC octreotate in intra-operative detection of neuroendocrine tumours of the gastrointestinal tract. Eur J Nucl Med Mol Imaging. 2007;34:1545-1555 (Pubitemid 47476926)
18. Freesmeyer M, Wurst C, Uberrueck T, et al. Intraoperative identification of a neuroendocrine tumour diagnosed by 68Ga-DOTATOC PET but undetectable by surgical palpation or conventional imaging. Nuklearmedizin. 2009; 48:N50-N51
19. Prasad V, Ambrosini V, Hommann M, et al. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging. 2010;37:67-77
20. Prasad V, Baum RP. Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging. 2010;54:61-67
21. Miederer M, Seidl S, Buck A, et al. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:48-52
22. Franko J, Feng W, Yip L, et al. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2158 patients. J Gastrointest Surg. 2010;14:541-548
23. Ong SL, Garcea G, Pollard CA, et al. A fuller understanding of pancreatic neuroendocrine tumours combined with aggressive management improves outcome. Pancreatology. 2009;9:583-600
24. Albertario S, Forti P, Bianchi C, et al. Radioguided surgery for gastrinoma: a case report. Tumori. 2002;88:S41-S43 (Pubitemid 34875476)
25. Hodul PJ, Strosberg JR, Kvols LK. Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated? Cancer Control. 2008;15:314-321
26. Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010;17:3129-3136
27. Schurr PG, Strate T, Rese K, et al. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg. 2007;245:273-281 (Pubitemid 46148487)
28. Adams S, Baum RP, Hertel A, et al. Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med. 1998;39:1155-1160 (Pubitemid 28326143)
29. Beltran MA, Cruces KS. Primary tumors of jejunum and ileum as a cause of intestinal obstruction: a case control study. Int J Surg. 2007;5:183-191 (Pubitemid 46727117)
30. Kim WW, Kim JS, Hur SM, et al. Radioguided surgery using an intraoperative PET probe for tumor localization and verification of complete resection in differentiated thyroid cancer: a pilot study. Surgery. 2011;149:416-424
31. Serrano Vicente J, Infante de la Torre JR, Dominguez Grande ML, et al. Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation in Spanish. Rev Esp Med Nucl.2010;29:8-11
32. DiNorcia J, Ahmed L, Lee MK, et al. Better preservation of endocrine function after central versus distal pancreatectomy for mid-gland lesions. Surgery. 2010;148:1247-1254; discussion 1254-1256.
33. Shikano T, Nakao A, Kodera Y, et al. Middle pancreatectomy: safety and long-term results. Surgery. 2010;147:21-29
34. Nalley C, Wiebeck K, Bartel TB, et al. Intraoperative radiation exposure with the use of (18)F-FDG-guided thyroid cancer surgery. Otolaryngol Head Neck Surg. 2010;142:281-283
35. Shannoun F, Blettner M, Schmidberger H, et al. Radiation protection in diagnostic radiology. Dtsch Arztebl Int. 2008;105:41-46 (Pubitemid 351373385)
36. Navez B, Arimont JM, Guiot P. Laparoscopic approach in acute small bowel obstruction. A review of 68 patients. Hepatogastroenterology. 1998;45:2146-2150 (Pubitemid 29055794)
37. Ohrvall U, Westlin JE, Nilsson S, et al. Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer. 1997;80:2490-2494 (Pubitemid 28009503)
38. Meller B, Sommer K, Gerl J, et al. High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancer. Nuklearmedizin. 2006;45:153-159 (Pubitemid 44366606)